Bitcoin is trading at $83,827, down 33.5% from its all-time high but up 9.1% over the past week. The key event influencing Bitcoin's near-term price is the U.S. Federal Reserve policy meeting on October 27-28, 2026, where a rate hike is largely priced in. Market participants should watch for any unexpected deviations from this expectation, which could cause significant price swings. German investors should also consider the 12-month holding period for tax purposes, as gains after this period are tax-free. Investors are advised to monitor turnover levels and leverage risks ahead of the Fed meeting to manage potential volatility effectively.
Bitcoin price prediction and related tax and leverage considerations are presented here with Pluang market data as of Sep 25, 2026 03:01 WIB. For readers following cryptocurrency markets, 44 of 50 major cryptocurrencies on Pluang rose today while 5 fell. Notable movers include LINK (Chainlink) up 8.45% at Rp236.781 with a typical hold time of 63 days and a Pluang order activity of 60% Sell / 40% Buy, EOS (EOS.IO) up 8.13% at Rp12.649 with a typical hold time of 87 days, and CRV (Curve DAO Token) up 8.06% at Rp6.288 with a typical hold time of 61 days and Pluang order activity of 58% Sell / 42% Buy.
Vistry Group reported a significant first-half pre-tax loss of £661.3 million, driven by a £475 million goodwill impairment and increased building safety costs. Revenue fell to £1.42 billion, and operational performance weakened with fewer home compl...
Vail Resorts is set to report its Q3 2026 earnings on September 28, with analysts forecasting a loss per share around -$5.30 and revenue near $271 million, indicating flat performance year-over-year. The company’s financial health shows a high Debt-t...
Western Union faces multiple analyst downgrades with price targets cut to as low as $6.00, reflecting concerns over its profitability and competitive pressures from fintech rivals. The stock has fallen over 15% in the past month, trading near $6.00, ...
Citigroup lowered ACADIA Pharmaceuticals' price target from $40 to $33 after its Alzheimer's drug remlifanserin missed the primary goal in a mid-stage trial, causing a 10.5% stock drop. Despite this, Citigroup kept a "Buy" rating, citing promising se...
Kroger is leveraging decades of retail data to implement an AI strategy aimed at enhancing customer experience and operational efficiency. The company reported earnings per share of $1.09, beating estimates, but revenue slightly missed projections at...
